The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need.


Updates from The Motley Fool

Latest updates on Cerus from Fool.com.
Cerus Gets a New Board Chairman

He will assume the position immediately, although the current chairman retires effective Dec. 31.



Stock Performance

View Interactive CERS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cerus.
Current Price: $4.28
Prev Close: $4.05
Open: $4.04
Bid: $4.28
Ask: $4.37
Day's Range: $4.02 - $4.30
52wk Range: $3.96 - $7.64
Volume: 1,364,109
Avg Vol 764,997
Market Cap: $442M
P/E (ttm): -6.53
EPS (ttm): ($0.62)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cerus.
CAPS Rating 1 out of 5
 
141 Outperform
16 Underperform
CAPS All Stars
 
16 Outperform
8 Underperform

How do you think Cerus will perform against the market?



You pick for Cerus is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

William M. (Obi) Greenman, CEO

36% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cerus.

The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers